Annual Cash & Cash Equivalents
$24.23 M
-$10.72 M-30.67%
31 December 2023
Summary:
Compass Therapeutics annual cash & cash equivalents is currently $24.23 million, with the most recent change of -$10.72 million (-30.67%) on 31 December 2023. During the last 3 years, it has fallen by -$22.85 million (-48.53%). CMPX annual cash & cash equivalents is now -83.23% below its all-time high of $144.51 million, reached on 31 December 2021.CMPX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$36.80 M
+$17.40 M+89.66%
01 September 2024
Summary:
Compass Therapeutics quarterly cash and cash equivalents is currently $36.80 million, with the most recent change of +$17.40 million (+89.66%) on 01 September 2024. Over the past year, it has increased by +$6.38 million (+20.95%). CMPX quarterly cash and cash equivalents is now -74.53% below its all-time high of $144.51 million, reached on 01 December 2021.CMPX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.7% | +20.9% |
| 3 y3 years | -48.5% | +44.3% |
| 5 y5 years | -57.9% | - |
CMPX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -83.2% | at low | -74.5% | +123.3% |
| 5 y | 5 years | -83.2% | at low | -74.5% | +123.3% |
| alltime | all time | -83.2% | at low | -74.5% | +123.3% |
Compass Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $36.80 M(+89.7%) |
| June 2024 | - | $19.40 M(-18.0%) |
| Mar 2024 | - | $23.67 M(-2.3%) |
| Dec 2023 | $24.23 M(-30.7%) | $24.23 M(-20.4%) |
| Sept 2023 | - | $30.43 M(+57.8%) |
| June 2023 | - | $19.28 M(-28.7%) |
| Mar 2023 | - | $27.03 M(-22.7%) |
| Dec 2022 | $34.95 M | $34.95 M(+112.0%) |
| Sept 2022 | - | $16.48 M(-37.2%) |
| June 2022 | - | $26.24 M(-80.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $136.38 M(-5.6%) |
| Dec 2021 | $144.51 M(+207.0%) | - |
| Dec 2021 | - | $144.51 M(+466.5%) |
| Sept 2021 | - | $25.51 M(-18.3%) |
| June 2021 | - | $31.21 M(-21.4%) |
| Mar 2021 | - | $39.70 M(-15.7%) |
| Dec 2020 | $47.08 M(+86.0%) | $47.08 M(-15.2%) |
| Sept 2020 | - | $55.52 M(-15.1%) |
| June 2020 | - | $65.37 M(+158.4%) |
| Dec 2019 | $25.30 M(-56.0%) | $25.30 M |
| Dec 2018 | $57.51 M | - |
FAQ
- What is Compass Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Compass Therapeutics?
- What is Compass Therapeutics annual cash & cash equivalents year-on-year change?
- What is Compass Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Compass Therapeutics?
- What is Compass Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Compass Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CMPX is $24.23 M
What is the all time high annual cash & cash equivalents for Compass Therapeutics?
Compass Therapeutics all-time high annual cash & cash equivalents is $144.51 M
What is Compass Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CMPX annual cash & cash equivalents has changed by -$10.72 M (-30.67%)
What is Compass Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CMPX is $36.80 M
What is the all time high quarterly cash and cash equivalents for Compass Therapeutics?
Compass Therapeutics all-time high quarterly cash and cash equivalents is $144.51 M
What is Compass Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CMPX quarterly cash and cash equivalents has changed by +$6.38 M (+20.95%)